Anhydroretinol and derivatives thereof as antagonists of immune

Details Anhydroretinol and derivatives thereof as antagonists of immune Anhydroretinol and derivatives thereof as antagonists of immune

1995-04-10

1997-03-11

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Hydrocarbon doai

514725, A61K 31015, A61K 3107

Patent

active

056102003

ABSTRACT:
This invention provides methods of inhibiting the growth of cells, of treating a subject having a disease characterized by an uncontrolled growth of cells and of blocking an immune response as well as related inflammatory responses in a subject which comprises administering a compound having the structure: ##STR1##

REFERENCES:
Buck, et al., "Retinol is Essential for Growth of Activated Human B Cells," J. Exp. Med., vol. 171, pp. 1613-1624, May, 1990.
Buck, et al., "Differences in the Action and Metabolism between Retinol and Retinoic Acid in B Lymphocytes," J. Cell Biol., vol. 115, pp. 851-859, Nov., 1991.
Garbe, et al., "Retinoids Are Important Cofactors in T Cell Activation," J. Exp. Med., vol. 176, pp. 109-117, Jul., 1992.
Buck, et al., "Intracellular Signaling by 14-Hydroxy-4, 14-Retro-Retinol," Science, vol. 254, pp. 1654-1656, Dec., 1991.
Wald, "Molecular Basis of Visual Excitation," Science, vol. 162, pp. 230-232, Oct., 1968.
Roberts, et al., "Cellular Biology and Biochemistry of the Retinoids," The Retinoids, vol. 2, (eds. M. D. Sporn, A. B. Roberts, and D. S. Goodman) pp. 209-286, 1984.
Evans, "The Steroid and Thyroid Hormone Receptor Superfamily," Science, vol. 240, pp. 889-895, May, 1988.
Green, et al., "Nuclear Receptors Enhance Our Understanding of Transcription Regulation," Trends in Genet., vol. 4, pp. 309-314, Nov., 1988.
Leo, et al., "Identification of a Monoclonal Antibody Specific for a Murine T3 Polypeptide," Proc. Natl. Acad. Sci. USA, vol. 84, pp. 1374-1378, Mar., 1987.
Gillis, et al., "Long Term Culture of Tumour-Specific Cytotoxic T Cells," Nature, vol. 268, pp. 154-156, Jul., 1977.
Cogan, et al., "Binding Affinities of Retinol and Related Compounds to Retinol Binding Proteins," Eur. J. Biochem., vol. 65, pp. 71-78, 1976.
McClean, et al., "Liquid-Chromatographic Assay for Retinol (Vitamin A) and Retinol Analogs in Therapeutic Trials," Clin. Chem., vol. 28, pp. 693-696, Apr., 1982.
Schreckenbach, et al., "Properties of the Retinal Binding Site in Bacteriorhodopsin: Use of Retinol and Retinyl Moieties as Fluorescent Probes," Photochem. Photobio., vol. 28, pp. 205-211, Aug., 1978.
Krishna Mallia, et al., "Preparation, Properties and Metabolism of retro-3-Dehydroretinyl Acetate," Biochem. J., vol. 109, pp. 293-299, 1968.
Favennec, et al., "The Biological Effects of Retinoids on Cell Differentiation and Proliferation," J. Clin. Chem. Clin. Biochem., vol. 26, pp. 479-489, 1988.
Shealy, "Synthesis and Evaluation of Some New Retinoids for Cancer Chemoprevention," Prev. Med., vol. 18, pp. 624-645, 1989.
Chemical Abstracts 102:125184u (1985).

Affiliated with

Also associated with

Rating

Anhydroretinol and derivatives thereof as antagonists of immune does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anhydroretinol and derivatives thereof as antagonists of immune , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anhydroretinol and derivatives thereof as antagonists of immune will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-444030